Background: Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, it has affected >200 countries, areas, or territories in 6 continents. At present, whether COVID-19 has an effect on thyroid function is unclear. The aim of this study was to evaluate thyroid function in iraqi patients with COVID-19.  Methods: Clinical features, laboratory results, and real time PCR were reviewed for 60 patients with laboratory-confirmed COVID-19 without a history of thyroid disease. They were admitted to the Al-Sadr Teaching Hospital; Iraq between September and December 2021. Healthy participants who underwent routine physical checkups and non-COVID-19 patients the study as the control group. Homocysteine and IL6 levels were determine and compared between the obese COVID-19 and control groups. Results: Homocysteine higher than the normal range of the patients with COVID-19 Compared to the control group. The levels of TSH and serum triiodothyronine (T3) of the patients with COVID-19 were significantly lower than those of the healthy control group. The lower the TSH and T3 levels were, with statistical significance (p <0.001). The degree of the decreases in TSH and T3 levels was positively correlated with the severity of the disease.

Background: Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, it has affected >200 countries, areas, or territories in 6 continents. At present, whether COVID-19 has an effect on thyroid function is unclear. The aim of this study was to evaluate Apolipoprotein in iraqi  patients with COVID-19. Methods: Clinical features, laboratory results, and real time PCR were reviewed for 60 patients with laboratory-confirmed COVID-19. They were admitted to the Al-Sadr Teaching Hospital; Iraq between September and December 2021. Healthy participants who underwent routine physical checkups and non-COVID-19 patients the study as the control group. Apolipoprotein B and Fibrinogen levels were determine and compared between the COVID-19 and control groups. Results: Fibrinogen protein B   lower than the normal range of the patients with COVID-19 Compared to the control group. The levels of Apolipoprotein of the patients with COVID-19 were significantly lower than those of the healthy control group. The lower the Fg and ABOB levels were, with statistical significance (p <0.001). Conclusions The Changing fibrinogen and apolipoprotein B  in the blood of people with Coronavirus may have a role in the infection and the life cycle of the virus.

Background: Since the exacerbation of the Coronal Virus 2019, caused by the SARS-COV-2 Virus in December 2019, affected more than 200 countries, region or region on 6 continents. Currently, the rates of infection for the male sex were higher than the female. The aim of this study was to assess the levels of Interleukin-6, the male-infected Iraqi patients with Covid-19. Methods: Clinical features, laboratory results and PCR actual time have been reviewed by 60 patients with a certain laboratory COVID-19 virus. They entered Al -Amal Hospital. Iraq between September and December 2021. Healthy participants who underwent routine physical examinations and non-patients with COVID-19 was the study as a control group. Homocysteine and IL6 levels have been identified and compared between the obese COVID-19 group and the control group. Results: The results showed that the levels of interleukin-6 were higher than the normal range for patients with COVID-19 compared to the control group, while the levels of interleukin-6 for the obese recorded the highest reading among the three groups. The lipid profile levels were high in the obese group of patients with COVID-19, while the non-obese patients with COVID-19 had a lower lipid profile compared to the healthy control group.